Respiratory depressant effects of fentanyl analogs are opioid receptor-mediated

Neil B Varshneya1, Sherif H Hassanien2, Melissa C Holt2

  • 1Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.

Biochemical Pharmacology
|October 21, 2021
PubMed

Insights

This study assessed the respiratory depressant effects of seven fentanyl analogs in mice. All analogs caused hypoventilation, with potency varying significantly, indicating a risk associated with these synthetic opioids.

Area of Science:

  • Pharmacology
  • Toxicology
  • Neuroscience

Background:

  • Synthetic opioids, particularly fentanyl analogs, are a major cause of drug-related fatalities.
  • Emerging fentanyl analogs in the illicit drug supply pose a significant public health threat.
  • Understanding the respiratory depressant effects of these analogs is crucial for harm reduction and clinical management.

Purpose of the Study:

  • To evaluate and compare the respiratory depressant potency of seven fentanyl analogs.
  • To determine the role of the mu-opioid receptor (MOR) in the hypoventilatory effects of these analogs.

Main Methods:

  • Adult male Swiss Webster mice were administered various doses of seven fentanyl analogs and standard MOR agonists (fentanyl, morphine, buprenorphine).
  • Whole body plethysmography (WBP) was used to measure minute volume and assess hypoventilation.
  • Naloxone pretreatment was employed to investigate the involvement of MOR.

Main Results:

  • All tested fentanyl analogs induced significant dose-dependent hypoventilation compared to vehicle.
  • A clear rank order of potency for hypoventilation was established, with fentanyl being the most potent and benzodioxolefentanyl the least potent among the analogs.
  • Naloxone effectively attenuated the hypoventilatory effects, confirming MOR mediation.

Conclusions:

  • The studied fentanyl analogs exhibit significant respiratory depressant properties mediated, at least in part, by the mu-opioid receptor.
  • The varying potencies highlight the unpredictable risks associated with the use of novel synthetic opioids.
  • These findings underscore the importance of monitoring and understanding the pharmacology of emerging synthetic opioids in public health surveillance.

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
520
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
465
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.4K
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
330
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
944
Depressants01:28

Depressants

Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
201